Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064607 · ClinicalTrials.gov registry record
Neurodegeneration in Newborns After Anesthetics
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 25
- Enrollment target
NCT03064607: Completed study, sponsored by University of Pennsylvania.
NCT03064607 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03064607 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of the study is to quantify biomarkers of neural damage in neonates exposed to varying levels of volatile anesthetic in utero.
Primary Outcome
as measured by the concentration of biomarker in umbilical arterial and venous blood
Interventions
- OTHER Fluid collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-11-05 |
| Est. Completion | 2018-02-06 |
What the finished NCT03064607 record still lists
NCT03064607 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fluid collection is the first listed.
NCT03064607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03064607 about?
NCT03064607 is a clinical study titled "Neurodegeneration in Newborns After Anesthetics". The purpose of the study is to quantify biomarkers of neural damage in neonates exposed to varying levels of volatile anesthetic in utero.
What is the current status of trial NCT03064607?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-11-05. Estimated completion is 2018-02-06.
What interventions are being tested in trial NCT03064607?
The interventions under investigation include: Fluid collection (OTHER).
Who is sponsoring clinical trial NCT03064607?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI